Xenon Pharmaceuticals Inc. (XENE) Cash Flow Statement
Xenon Pharmaceuticals Inc. (XENE) generated -$337.5M of operating cash flow over the twelve months to 2026-06-30, spent $1.0M on capital expenditure and had free cash flow of -$338.5M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
XENEXenon Pharmaceuticals Inc.Follow XENE — free
—
Price chart with a free account
- Market cap
- 3.4B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
| Line | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 0.00 | -0.02 | -0.02 | -0.03 | -0.00 | -0.05 | -0.07 | -0.10 | -0.28 | -0.34 | |
| Capital expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | |
| Free cash flow | -0.00 | -0.02 | -0.02 | -0.03 | -0.01 | -0.05 | -0.07 | -0.10 | -0.28 | -0.34 | |
| Stock-based compensation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.05 | — |
USD billions · SEC XBRL
Xenon Pharmaceuticals Inc. — questions
- What is Xenon Pharmaceuticals Inc.'s operating cash flow?
- -$337.5M over the twelve months to 2026-06-30.
- How much does Xenon Pharmaceuticals Inc. spend on capital expenditure?
- $1.0M over the twelve months to 2026-06-30.
- What is Xenon Pharmaceuticals Inc.'s free cash flow?
- -$338.5M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Xenon Pharmaceuticals Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.